Thick melanoma: The problem continues

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 5, 2008, Pages 575-579

  Tejera vaquerizo, Antonio ^a   Mendiola fernandez M ^a   Fernandez orland A ^a   Herrera ceballos, E ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Epidemiology; Melanoma; Patient characteristics; Thick melanoma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; EARLY DIAGNOSIS; EDUCATION PROGRAM; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; PRIORITY JOURNAL; RISK REDUCTION; SEX DIFFERENCE; SPAIN; STATISTICAL ANALYSIS; THICKNESS; TUMOR VOLUME; UNIVERSITY HOSPITAL;

FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SPAIN;

EID: 42149140541     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02517.x     Document Type: Article

References (23)

1. De Vries E, Bray FE, Coewergh FWW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-97. rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003; 107: 119-126.
2. Nieto A, Ruiz-Ramos M, Abdel-Kader L, Conde M, Camacho F. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98. Br J Dermatol 2003; 148: 110-116.
3. Cayuela A, Rodríguez-Domínguez S, Lapetra-Peralta J, Conejo-Mir JS. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001. Br J Dermatol 2005; 152: 997-1000.
4. Saenz S, Conejo-Mir J, Cayuela A. Epidemiología del melanoma en España. Actas Dermatosifiliogr 2005; 96: 411-418.
5. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.
6. Balch CM, Soong SJ, Atkins MB et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004; 54: 131-149.
7. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 2006; 17: 21-27.
8. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93: 678-683.
9. Murray CS, Stockon DL, Doherty VR. Thick melanoma: The challenge persists. Br J Dermatol 2005; 152: 104-109.
10. Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States. Arch Dermatol 2005; 141: 745-750.
11. Berwick M. Why are people still dying from melanoma? Arch Dermatol 1999; 135: 1534-1536.
12. Carli P. Identifications of incipient tumours by means of sequential dermoscopy imaging: A new way to inflate the 'epidemic' melanoma? Arch Dermatol 2007; 143: 805.
13. Conejo-Mir J, Bravo J, Díaz-Perez JL et al. Día del Euromelanoma. Resultados en España de las campañas de 2000, 2001 y 2002. Actas Dermosifiliogr 2005: 96: 217-221.
14. Vandaele MM, Richert B, Van der Endt JD et al. Melanoma screening: results of the first one-day campaign in Belgium ('melanoma Monday'). J Eur Acad Dermatol Venereol 2000; 14: 470-472.
15. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria. Australia Arch Dermatol 2002; 138: 609-614.
16. Richard MA, Grob JJ, Avril MF et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol 1999; 135: 269-274.
17. Chamberlain AJ, Fritschi L, Kelly JW. Nodular melanoma: Patient′ perceptions of presenting features and implications for earlier detection. J Am Acad Dermatol 2003; 48: 694-701.
18. Kelly JW, Chamberlain AJ, Staples MP, McAvoy B. Nodular melanoma. No longer as simple as ABC. Aust Fam Physician 2003; 32: 706-709.
19. Liu W, Dowling JP, Murray WK et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol, 2006; 142: 1551-1558.
20. Lipsker D, Engel F, Cribier B, Velten M, Hedelin G. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 2007; 157: 338-343.
21. Whiteman DC, Green A, Parsons PG. p53 expression and risk factors for cutaneous melanoma: A case-control study. Int J Cancer 1998; 77: 843-848.
22. Holme SA, Varma S, Chowdhury MMU, Robert DL. Audit of a melanoma screening day in the UK clinical results, participant satisfaction and perceived value. Br J Dermatol 2001; 145: 784-788.
23. Demierre MF. Thin melanomas and regression, thick melanomas and older men: Prognostic implications and perspectives on secondary prevention. Arch Dermatol 2002; 138: 678-682.